News
Avicenna Alliance continues to grow by welcoming VCLS among its members
The Avicenna Alliance is happy to welcome its newest member: Voisin Consulting Life Sciences.
The Council of the European Union adopted conclusions on AI
The Council of the European Union – under the Competitiveness formation, gathering the Ministers of the Member States – adopted conclusions on the "Coordinated Plan on Artificial Intelligence (AI)" on 18 February 2019. Overall, the Council welcomes the European Commission's communication on the "Coordinated Plan on Artificial Intelligence" published on 7 December 2018.
In silico method mentioned in JRC report on alternatives to animal testing
On 7 February, the European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) - which is an integral part of the European Commission's Joint Research Centre (JRC) – published a status report on alternatives to animal testing. This report provides updates on the progress made in research, development and validation activities as well as on initiatives promoting the regulatory and international adoption and use of alternative approaches and their dissemination.
Artificial Intelligence and clinical research: which issues remain?
This issue is discussed in the new article written under the direction of Vincent Diebolt, Director of the French Clinical Research Infrastructure Network (F-CRIN), entitled “Artificial Intelligence”: which services, which applications, which results and which development today in clinical research? Which impacts on the quality of care? Which recommendations?, published at the end of 2018.
FEops joins Avicenna Alliance
As further evidence of the Alliance’s growing momentum, Avicenna Alliance is happy to announce the newest addition to our list of members: FEops.
Commission participates to international In Silico Toxicology Protocol initiative
The European Commission’s Joint Research Center (JRC) Directorate published on 22 November an article highlighting that JRC scientists are part of the international In Silico Toxicology (IST) Protocol initiative developing principles and protocols for the consistent use of computational models in chemical safety assessment to promote greater acceptance in regulatory applications.
